Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis by Sasaki, Koji, Kantarjian, Hagop, Jabbour, Elias, Ravandi, Farhad, Takahashi, Koichi, Konopleva, Marina, Borthakur, Gautam, Garcia-Manero, Guillermo, Wierda, William, Daver, Naval, Jain, Preetesh, Satta, Toshihisa, Pierce, Sherry, Rios, May Beth, Cortes, Jorge E

Get full text

Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax by Satta, Toshihisa, Li, Lin, Chalasani, Sri Lakshmi, Hu, Xiaoyan, Nkwocha, Jewel, Sharma, Kanika, Kmieciak, Maciej, Rahmani, Mohamed, Zhou, Liang, Grant, Steven

Get full text

Clinical experience of CAR T cells for multiple myeloma by Simmons, Gary L., Satta, Toshihisa, Castaneda Puglianini, Omar

Get full text

Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd by Satta, Toshihisa, Papadopoulos, Esperanza B., Gyurkocza, Boglarka, Susman, Pamela, Singh, Amandeep, Calafiore, Marco, Giralt, Sergio A., Perales, Miguel-Angel, Chen, Jianmin, Li, Simon, Peled, Jonathan U., van den Brink, Marcel R.M., Hanash, Alan M., Ponce, Doris M.

Get full text

Bayesian Network Meta-Analysis (NMA): Safety of Bortezomib, Thalidomide or Lenalidomide Containing Regimens for Transplant Ineligible Multiple Myeloma (MM) Patients by Satta, Toshihisa, Yamaguchi, Norihiro, Malone, Adriana, Talcott, James, Chari, Ajai

Get full text

Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells... by Leng, Yun, Hu, Xiaoyan, Li, Lin, Nkwocha, Jewel, Satta, Toshihisa, Sharma, Kanika, Kmeiciak, Maciej, Zhou, Huixing, Zhang, Zhiyao, Zhou, Liang, Chen, Wenming, Grant, Steven

Get full text

Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma by Chari, Ajai, Arinsburg, Suzanne, Jagannath, Sundar, Satta, Toshihisa, Treadwell, Ivey, Catamero, Donna, Morgan, Gillian, Feng, Huaibao, Uhlar, Clarissa, Khan, Imran, Doshi, Parul, Usmani, Saad

Get full text

High-grade neuroendocrine carcinoma of the bladder (large cell and small cell mixed): a literature review and case report of a rare bladder tumor by Satta, Toshihisa, Sasaki, Koji, Tsuura, Yukio, Shioi, Koichi

Get full text

Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab by Chari, Ajai, Satta, Toshihisa, Tayal, Amit, Jagannath, Sundar, Cho, Hearn Jay, Parekh, Samir, Lau, Kenneth, Morgan, Gillian, Catamero, Donna, Escalon, Juliet, Florendo, Erika, Verina, Daniel, Doshi, Parul, Feng, Huaibao, Uhlar, Clarissa, Khan, Imran, Ahmadi, Tahamtan, Voorhees, Peter M., Mateos, Maria-Victoria, Arinsburg, Suzanne

Get full text

Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd by Satta, Dr. Toshihisa, Papadopoulos, Esperanza B., Gyurkocza, Boglarka, Susman, Pamela, Singh, Amandeep, Calafiore, Marco, Giralt, Sergio A., Perales, Miguel-Angel, Li, Simon, Chen, Jianmin, Peled, Jonathan U., van den Brink, Marcel R.M., Hanash, Alan M., Ponce, Doris M.

Get full text

Risk factors for rebleeding in gastroduodenal ulcers by Ito, Nobuhito, Funasaka, Kohei, Fujiyoshi, Toshihisa, Nishida, Kazuki, Satta, Yusuke, Furukawa, Kazuhiro, Kakushima, Naomi, Furune, Satoshi, Ishikawa, Eri, Mizutani, Yasuyuki, Sawada, Tsunaki, Maeda, Keiko, Ishikawa, Takuya, Yamamura, Takeshi, Ohno, Eizaburo, Nakamura, Masanao, Miyahara, Ryoji, Sasaki, Yoji, Haruta, Jun-Ichi, Fujishiro, Mitsuhiro, Kawashima, Hiroki

Get full text